Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 111
Filter
1.
Ecotoxicol Environ Saf ; 208: 111711, 2021 Jan 15.
Article in English | MEDLINE | ID: mdl-33396042

ABSTRACT

PURPOSE: Salt iodization in Manipur of north-east India failed to prevent endemic goiter, therefore an in depth study carried out to evaluate thyroid functions of goitrous subjects in a randomly selected region. METHODS: Goiter survey conducted in children and women of reproductive ages by palpation followed by measurement of urinary iodine, thiocyanate and house-hold salt iodine to evaluate iodine nutritional status and consumption pattern of bamboo-shoots (BS). In all grade-2 goitrous subjects, free thyroxine, triiodothyronine, TSH, TPO and Tg antibodies, thyroid volume and echogenecity by ultrasonography and cytomorphology of thyroid by FNAC studied. RESULTS: Study population was 2486 children and 1506 women, goiter prevalence was 12.59% and 16.27% respectively; median urinary iodine and mean thiocyanate were 166 µg/l and 0.729 ± 0.408 mg/dl while salt iodine was ≥30 ppm. Serum thyroid hormones and TSH profiles of all grade-2 goitrous subjects showed 16.21% were subclinically hypothyroid, 2.16% overt hypothyroid, 4.86% subclinically hyperthyroid and 6.48% overt hyperthyroid, serum TPO- and Tg-antibodies found positive in 41.62%. Ultrasonographic results showed 24% had enlarged thyroid and 86.4% hypoechoic. Cytomorphological studies showed prevalence of colloid goiter (41.08%), lymphocytic thyroiditis (37.83%), Hashimoto's thyroiditis (8.10%), autoimmune thyroiditis (4.32%), sub-acute thyroiditis (2.16%) and 1.62% each papillary, medullary carcinoma, simple diffused hyperplasia and adenomoid nodular goiter. CONCLUSIONS: Grade-2 goitrous individuals in this mild goiter endemic region were affected by hypo- and hyperthyroidism with hypoechoic thyroid and thyroiditis. Thiocyanate that originates from BS even in presence of adequate iodine developed goiter and led goitrous population towards such diseases.


Subject(s)
Dietary Exposure/adverse effects , Goiter, Endemic/chemically induced , Iodine/administration & dosage , Sodium Chloride, Dietary/administration & dosage , Thiocyanates/adverse effects , Adult , Autoantibodies/blood , Bambusa/adverse effects , Bambusa/chemistry , Child , Dietary Exposure/statistics & numerical data , Female , Goiter, Endemic/diagnosis , Goiter, Endemic/epidemiology , Goiter, Endemic/immunology , Humans , India/epidemiology , Iodine/urine , Male , Prevalence , Rural Health/statistics & numerical data , Thiocyanates/urine , Thyroid Gland/pathology , Thyroid Gland/physiopathology , Thyroid Hormones/blood , Thyrotropin/blood
2.
Contact Dermatitis ; 81(4): 262-265, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31006870

ABSTRACT

BACKGROUND: Allergic contact dermatitis caused by leather is common, and several responsible allergens, such as tanning agents, glues, mercaptobenzothiazole derivatives, and dyes, but also antimicrobials and antifungals, are involved. MATERIAL AND METHODS: Three female patients were referred to the Departments of Dermatology in a Belgian university hospital following skin reactions caused by leather products (shoes, belt, and car seats). They were patch tested with the European baseline series and samples of suspected leather products, and additionally with 2-(thiocyanomethylthio)benzothiazole (TCMTB), an antifungal agent previously reported to be a contact allergen in footwear. Chromatographic analyses of samples of all the leather materials tested were performed at the Department of Occupational and Environmental Dermatology in Malmö, Sweden. RESULTS: The patients reacting to the leather samples were shown to be sensitized to TCMTB, the presence of which could be confirmed by chemical analyses of samples obtained from the patients. CONCLUSION: Patch tests with TCMTB should be considered in patients with contact dermatitis caused by leather items.


Subject(s)
Antifungal Agents/adverse effects , Benzothiazoles/adverse effects , Dermatitis, Allergic Contact/etiology , Foot Dermatoses/chemically induced , Leg Dermatoses/chemically induced , Thiocyanates/adverse effects , Adolescent , Adult , Automobiles , Dermatitis, Allergic Contact/diagnosis , Female , Humans , Middle Aged , Patch Tests , Shoes
3.
J Clin Endocrinol Metab ; 102(7): 2637-2645, 2017 07 01.
Article in English | MEDLINE | ID: mdl-28430972

ABSTRACT

Context: Common environmental contaminants can disrupt normal thyroid function, which plays essential but varying roles at different ages. Objective: To evaluate the relationship of perchlorate, thiocyanate, and nitrate, three sodium-iodide symporter (NIS) inhibitors, and thyroid function in different age-sex-stratified populations. Design, Setting, Participants, and Intervention: This was a cross-sectional analysis of data from the 2009 to 2012 National Health and Nutrition Examination Survey evaluating the exposure to perchlorate, thiocyanate, and nitrate in 3151 participants aged 12 to 80. Main Outcome Measure: Blood serum free thyroxine (FT4) as both a continuous and categorical variable. We also assessed blood serum thyroid stimulating hormone. Results: Controlling for serum cotinine, body mass index, total daily energy consumption, race/ethnicity, and poverty-to-income ratio, for each log unit increase in perchlorate, FT4 decreased by 0.03 ng/dL in both the general population (P = 0.004) and in all women (P = 0.005), and by 0.06 ng/dL in adolescent girls (P = 0.029), corresponding to 4% and 8% decreases relative to median FT4, respectively. For each log unit increase thiocyanate, FT4 decreased by 0.07 ng/dL in adolescent boys (P = 0.003), corresponding to a 9% decrease relative to median FT4, respectively. Conclusions: Our results indicate that adolescent boys and girls represent vulnerable subpopulations to the thyroid-blocking effects of NIS symporter inhibitors. These results suggest a valuable screening and intervention opportunity.


Subject(s)
Environmental Exposure/adverse effects , Perchlorates/adverse effects , Thiocyanates/adverse effects , Thyroid Gland/physiopathology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Cross-Sectional Studies , Female , Humans , Linear Models , Male , Middle Aged , Multivariate Analysis , Perchlorates/chemistry , Retrospective Studies , Risk Assessment , Sex Factors , Thiocyanates/chemistry , Thyroid Function Tests , Thyrotropin/blood , Thyroxine/blood , Vulnerable Populations , Young Adult
4.
Oxid Med Cell Longev ; 2017: 1054801, 2017.
Article in English | MEDLINE | ID: mdl-29359006

ABSTRACT

Inhaled corticosteroids (ICSs) are used as first-line drugs for asthma, and various novel antiasthma drugs targeting type 2 immune mediators are now under development. However, molecularly targeted drugs are expensive, creating an economic burden on patients. We and others previously found pendrin/SLC26A4 as a downstream molecule of IL-13, a signature type 2 cytokine critical for asthma, and showed its significance in the pathogenesis of asthma using model mice. However, the molecular mechanism of how pendrin causes airway inflammation remained elusive. We have recently demonstrated that hypothiocyanite (OSCN-) produced by the pendrin/DUOX/peroxidase pathway has the potential to cause airway inflammation. Pendrin transports thiocyanate (SCN-) into pulmonary lumens at the apical side. Peroxidases catalyze SCN- and H2O2 generated by DUOX into OSCN-. Low doses of OSCN- activate NF-κB in airway epithelial cells, whereas OSCN- in high doses causes necrosis of the cells, inducing the release of IL-33 and accelerating inflammation. OSCN- production is augmented in asthma model mice and possibly in some asthma patients. Heme peroxidase inhibitors, widely used as antithyroid agents, diminish asthma-like phenotypes in mice, indicating the significance of this pathway. These findings suggest the possibility of repositioning antithyroid agents as antiasthma drugs.


Subject(s)
Asthma/pathology , Dual Oxidases/metabolism , Membrane Transport Proteins/metabolism , Peroxidase/metabolism , Signal Transduction/drug effects , Thiocyanates/adverse effects , Asthma/chemically induced , Asthma/metabolism , Humans , Sulfate Transporters , Thiocyanates/metabolism
5.
J Biol Chem ; 291(53): 27219-27227, 2016 12 30.
Article in English | MEDLINE | ID: mdl-27864363

ABSTRACT

Hypothiocyanite (OSCN-) serves as a potent innate defense system against microbes in the lungs. OSCN- is generated by the catalysis of peroxidases using thiocyanate transported via several anion transporters, including pendrin/SLC26A4 and hydrogen peroxide (H2O2) generated by Duox1 and Duox2. We previously demonstrated that expression of pendrin, peroxidases, and Duox1/Duox2 is up-regulated in bronchial asthma patients and/or asthma model mice and that these molecules are important in accelerating airway inflammation. However, it remained unclear how activating these molecules would lead to airway inflammation. In this study, we examined whether OSCN- produced via the pendrin/peroxidase/Duox pathway causes inflammation via airway epithelial cells. In an in vitro OSCN- production system, OSCN-, but not H2O2, activated NF-κB, a transcription factor critical for inflammatory responses, in the airway epithelial cells. OSCN- was sensed by protein kinase A (PKA) followed by formation of the dimerization of PKA. The dimerized PKA, the active form, was critical in activating NF-κB. Detoxifying H2O2, mainly by catalase, enabled the dominant abilities of OSCN- to dimerize PKA and activate NF-κB, compared with untreated H2O2 Furthermore, OSCN- in high doses caused necrosis of the cells, inducing release of IL-33, a trigger to initiate type 2 inflammation. These results demonstrate that OSCN- in low doses activates NF-κB via PKA in airway epithelial cells, whereas OSCN- in high doses causes necrosis, suggesting an important role in airway allergic inflammation for the production of OSCN- via the pendrin/peroxidase/Duox pathway.


Subject(s)
Apoptosis/drug effects , Epithelial Cells/pathology , Hypersensitivity/pathology , Inflammation/chemically induced , Respiratory System/pathology , Thiocyanates/adverse effects , Animals , Anti-Infective Agents/adverse effects , Cells, Cultured , Epithelial Cells/drug effects , Humans , Hydrogen Peroxide/pharmacology , Hypersensitivity/etiology , Inflammation/metabolism , Inflammation/pathology , Mice , Oxidants/pharmacology , Respiratory System/drug effects
6.
Environ Res ; 123: 17-24, 2013 May.
Article in English | MEDLINE | ID: mdl-23473920

ABSTRACT

Perchlorate, thiocyanate, and low iodine intake can all decrease iodide intake into the thyroid gland. This can reduce thyroid hormone production since iodide is a key component of thyroid hormone. Previous research has suggested that each of these factors alone may decrease thyroid hormone levels, but effect sizes are small. We hypothesized that people who have all three factors at the same time have substantially lower thyroid hormone levels than people who do not, and the effect of this combined exposure is substantially larger than the effects seen in analyses focused on only one factor at a time. Using data from the 2007-2008 National Health and Nutrition Examination Survey, subjects were categorized into exposure groups based on their urinary perchlorate, iodine, and thiocyanate concentrations, and mean serum thyroxine concentrations were compared between groups. Subjects with high perchlorate (n=1939) had thyroxine concentrations that were 5.0% lower (mean difference=0.40 µg/dl, 95% confidence interval=0.14-0.65) than subjects with low perchlorate (n=2084). The individual effects of iodine and thiocyanate were even smaller. Subjects with high perchlorate, high thiocyanate, and low iodine combined (n=62) had thyroxine concentrations 12.9% lower (mean difference=1.07 µg/dl, 95% confidence interval=0.55-1.59) than subjects with low perchlorate, low thiocyanate, and adequate iodine (n=376). Potential confounders had little impact on results. Overall, these results suggest that concomitant exposure to perchlorate, thiocyanate, and low iodine markedly reduces thyroxine production. This highlights the potential importance of examining the combined effects of multiple agents when evaluating the toxicity of thyroid-disrupting agents.


Subject(s)
Environmental Pollutants/adverse effects , Iodine/deficiency , Perchlorates/adverse effects , Thiocyanates/adverse effects , Thyroid Gland/drug effects , Adult , Drug Interactions , Female , Humans , Linear Models , Male , Middle Aged , Nutrition Surveys , Thyroid Function Tests , Young Adult
7.
Wien Med Wochenschr ; 163(3-4): 80-8, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23224634

ABSTRACT

The plant family Brassicaceae, formerly Cruciferae, contains mustard oil glycosides, from which mustard oils are enzymatically hydrolyzed. Mustard oils offer protection from pests, microorganisms and fungi. More than 120 different mustard oils with various biological functions are known. Since ancient times, these substances are used as natural antibiotics, antiviral drugs and antimycotics. The antioxidative effect of mustard oils contributes to protection from DNA damage. Epidemiological and experimental studies have shown preventive and therapeutic effects of crucifers or isolated substances thereof. Particularly well studied is the mustard oil sulforaphane, which is contained in high concentrations in broccoli and its sprouts. As has been shown in mice recently, sulforaphane also targets the most malignant cancer stem cells, which are not affected by conventional cancer treatments. Based on these promising results, the first prospective clinical studies with cancer patients and sulforaphane-enriched broccoli sprouts have now been initiated in the United States.


Subject(s)
Anticarcinogenic Agents/therapeutic use , Neoplasms/drug therapy , Neoplasms/prevention & control , Phytotherapy/methods , Plant Extracts/therapeutic use , Thiocyanates/therapeutic use , Animals , Anticarcinogenic Agents/adverse effects , Brassica , Case-Control Studies , DNA Damage/drug effects , Feeding Behavior , Glucosinolates/adverse effects , Glucosinolates/therapeutic use , Herb-Drug Interactions , Humans , Isothiocyanates , Mice , Neoplasms, Experimental/drug therapy , Neoplastic Stem Cells/drug effects , Sulfoxides , Thiocyanates/adverse effects , Transplantation, Heterologous
8.
J Med Food ; 15(9): 795-801, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22925073

ABSTRACT

Diabetes has reached epidemic levels in the whole world, and the use of bioactive compounds that may have the capacity to prevent and treat diabetes is of great interest. Sulforaphane (SFN) is a compound which is found in cruciferous vegetables and that acts as both a potent antioxidant and regulator of gene expression. The aim of this study was to evaluate the effect of SFN in diabetes induced by streptozotocin (STZ). Male Wistar rats were gavaged with water or 0.1, 0.25, or 0.5 mg/kg of SFN before an injection of STZ (80 mg/kg). Animals treated with SFN showed fasting glycemia, insulin sensitivity, and hepatic glycogen concentrations, similar to the control group (nondiabetic), and different from the diabetic group. Diabetic animals also presented elevated levels of serum triacylglycerols (TAG), urea, and creatinine, and all SFN doses were able to reverse these alterations. However, the same doses of SFN accentuated alterations in total cholesterol, alanine, and aspartate aminotransferase levels, and had no effect on hepatic TAG, HDL cholesterol, and uptake of 2-deoxy glucose in adipose tissue and soleum muscle. Based on the effects inferred by the present data, SFN presented some positive effects against diabetes induction, although the impairment of hepatic function and cholesterol levels were aggravated after treatment with the compound.


Subject(s)
Antioxidants/therapeutic use , Diabetes Mellitus, Type 1/prevention & control , Dietary Supplements , Glucose/metabolism , Hypoglycemic Agents/therapeutic use , Insulin Resistance , Thiocyanates/therapeutic use , Animals , Antioxidants/administration & dosage , Antioxidants/adverse effects , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/physiopathology , Diabetic Nephropathies/prevention & control , Dietary Supplements/adverse effects , Hepatic Insufficiency/complications , Hepatic Insufficiency/etiology , Hypercholesterolemia/complications , Hypercholesterolemia/etiology , Hyperglycemia/prevention & control , Hypertriglyceridemia/complications , Hypertriglyceridemia/prevention & control , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/adverse effects , Intra-Abdominal Fat/metabolism , Isothiocyanates , Liver/metabolism , Liver/physiopathology , Liver Glycogen/metabolism , Male , Muscle, Skeletal/metabolism , Random Allocation , Rats , Rats, Wistar , Streptozocin , Sulfoxides , Thiocyanates/administration & dosage , Thiocyanates/adverse effects
9.
Thyroid ; 22(9): 938-43, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22827469

ABSTRACT

BACKGROUND: Breastfed infants rely on maternal iodine for thyroid hormone production required for neurodevelopment. Dietary iodine among women of childbearing age in the United States may be insufficient. Perchlorate (competitive inhibitor of the sodium/iodide symporter [NIS]) exposure is ubiquitous. Thiocyanate, from cigarettes and diet, is a weaker NIS inhibitor. Environmental perchlorate and thiocyanate exposures could decrease breast milk iodine by competitively inhibiting NIS in lactating breasts (thus impairing infants' iodine availability), and/or infants' thyroidal NIS to directly decrease infant thyroid function. The current study assessed the relationships between environmental perchlorate and thiocyanate exposures and infant serum thyroid function. METHODS: Iodine, perchlorate, and thiocyanate in breast milk, maternal and infant urine, and infant serum thyroid function tests were cross-sectionally measured in Boston-area women and their 1-3 month-old breastfed infants. Univariate and multivariable analyses assessed relationships between iodine, perchlorate, thiocyanate, thyroid-stimulating hormone (TSH), and free thyroxine (FT4) levels. RESULTS: In 64 mothers and infants, median (range) iodine levels were 45.6 µg/L (4.3-1080) in breast milk, 101.9 µg/L (27-570) in maternal urine, and 197.5 µg/L (40-785) in infant urine. Median perchlorate concentrations were 4.4 µg/L (0.5-29.5) in breast milk, 3.1 µg/L (0.2-22.4) in maternal urine, and 4.7 µg/L (0.3-25.3) in infant urine. There were no correlations between infant TSH or FT4 and iodine, perchlorate, and thiocyanate levels in breast milk, maternal urine, and infant urine. In multivariable analyses, perchlorate and thiocyanate levels in breast milk, maternal urine, and infant urine were not significant predictors of infant TSH or FT4. CONCLUSIONS: Boston-area mothers and their breastfed infants are generally iodine sufficient. Although environmental perchlorate and thiocyanate are ubiquitous, these results do not support the concern that maternal and infant environmental perchlorate and thiocyanate exposures affect infant thyroid function.


Subject(s)
Environmental Exposure , Milk, Human/chemistry , Perchlorates/adverse effects , Prenatal Exposure Delayed Effects/chemically induced , Thiocyanates/adverse effects , Adult , Boston , Breast Feeding , Cross-Sectional Studies , Female , Humans , Infant , Iodine/analysis , Iodine/urine , Perchlorates/analysis , Perchlorates/urine , Pregnancy , Thiocyanates/analysis , Thiocyanates/urine , Thyroid Function Tests , Thyroid Gland/chemistry , Thyroid Gland/metabolism , Thyrotropin/blood , Thyrotropin/urine , Thyroxine/analysis , Thyroxine/blood , Thyroxine/urine , Young Adult
10.
Clin Endocrinol (Oxf) ; 77(3): 471-4, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22486757

ABSTRACT

OBJECTIVE: Thyroid hormone, requiring adequate maternal iodine intake, is critical for neurodevelopment in utero. Perchlorate and, less so, thiocyanate decrease uptake of iodine into the thyroid gland by competitively inhibiting the sodium/iodide symporter (NIS). It remains unclear whether environmental perchlorate exposure adversely affects thyroid function in first-trimester pregnant women. DESIGN: Cross-sectional. PATIENTS: 134 pregnant women from Athens, Greece, at mean ± SD 10·9 ± 2·3 weeks' gestation. MEASUREMENTS: Urinary iodide, perchlorate, and thiocyanate and thyroid function tests were measured. RESULTS: The median urinary iodide was 120 µg/l. Urinary perchlorate levels were detectable in all women: median (range) 4·1 (0·2-118·5) µg/l. Serum thyroperoxidase antibodies (TPO Ab) were detectable in 16% of women. Using Spearman's rank correlation analyses, there was no correlation between urinary perchlorate concentrations and serum TSH, although inverse correlations were seen between urine perchlorate and free T3 and free T4 values. In univariate analyses, urine thiocyanate was positively correlated with serum TSH, but was not associated with serum free T3 or free T4. Urine perchlorate was positively correlated with gestational age. In multivariate analyses adjusting for urinary iodide concentrations, urine thiocyanate, gestational age, maternal age and TPO Ab titres, urine perchlorate was not a significant predictor of thyroid function. CONCLUSIONS: Low-level perchlorate and thiocyanate exposure is ubiquitous, but, in adjusted analyses, is not associated with alterations in thyroid function tests among mildly iodine-deficient Greek women in the first trimester of pregnancy.


Subject(s)
Environmental Exposure/adverse effects , Perchlorates/adverse effects , Pregnancy/drug effects , Pregnancy/physiology , Thiocyanates/adverse effects , Thyroid Gland/drug effects , Thyroid Gland/physiopathology , Adult , Female , Fetal Development/drug effects , Greece , Humans , Iodides/urine , Iodine/deficiency , Perchlorates/urine , Pregnancy Trimester, First , Thiocyanates/urine , Thyroid Function Tests , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood
11.
J Immunotoxicol ; 8(2): 150-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21401388

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is currently the fifth leading cause of death worldwide. Exposure to cigarette smoke (CS) is the primary factor associated with the COPD development. CS activates epithelial cells to secrete chemokines such as interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) that recruit neutrophils and macrophages to the lung. These inflammatory cells then release additional chemokines and cytokines leading to chronic inflammation that initiates apoptosis in epithelial and endothelial cells and destruction of alveolar structure. Pulmonary epithelium responds to oxidative stress mediated by CS through activating NRF2-dependent pathways, leading to an increased expression of antioxidant and cytoprotective enzymes thereby providing a protective response against CS-induced lung injury. We hypothesized that activating NRF2-dependent cytoprotective gene expression with sulforaphane (SFN) affords protection against CS-induced lung damage by inhibiting chemokine production. Results indicate that in the human BEAS-2B epithelial cell line, 5 µM SFN activated NRF2-dependent gene expression by triggering the translocation of NRF2 to the nucleus and significantly increased the expression of NRF2-dependent genes such as NADPH quinone oxidoreductase-1, heme oxygenase-1, and glutamate cysteine ligase modulatory subunit. Cigarette smoke extract (CSE) exposure of BEAS-2B cells significantly increased production of both IL-8 and MCP-1. Production of both chemokines was significantly reduced with SFN given prior to CSE; SFN inhibited IL-8 and MCP-1 gene expression at the transcription level. Our results indicate that activating NRF2 pathways with SFN inhibits CSE-induced chemokine production in human epithelial cells. However, the mechanism by which the production of chemokines is inhibited through SFN still remains to be elucidated. SFN may enhance NRF2 transcriptional activity resulting in the inhibition of proinflammatory pathways such as NF-κB.


Subject(s)
Anticarcinogenic Agents/adverse effects , Chemokine CCL2/immunology , Epithelial Cells/immunology , Gene Expression Regulation/drug effects , Interleukin-8/immunology , Thiocyanates/adverse effects , Anticarcinogenic Agents/pharmacokinetics , Cell Line , Chemokine CCL2/biosynthesis , Epithelial Cells/metabolism , Epithelial Cells/pathology , Gene Expression Regulation/immunology , Glutamate-Cysteine Ligase/immunology , Glutamate-Cysteine Ligase/metabolism , Heme Oxygenase-1/immunology , Heme Oxygenase-1/metabolism , Humans , Interleukin-8/biosynthesis , Isothiocyanates , NAD(P)H Dehydrogenase (Quinone)/immunology , NAD(P)H Dehydrogenase (Quinone)/metabolism , NF-E2-Related Factor 2/immunology , NF-E2-Related Factor 2/metabolism , NF-kappa B/metabolism , Pulmonary Alveoli/immunology , Pulmonary Alveoli/metabolism , Pulmonary Alveoli/pathology , Pulmonary Disease, Chronic Obstructive/etiology , Pulmonary Disease, Chronic Obstructive/immunology , Pulmonary Disease, Chronic Obstructive/metabolism , Pulmonary Disease, Chronic Obstructive/pathology , Smoke/adverse effects , Smoking/adverse effects , Sulfoxides , Thiocyanates/pharmacology
12.
Inflamm Res ; 59(6): 443-50, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19924513

ABSTRACT

OBJECTIVE AND DESIGN: The aim of this study was to investigate the signal transduction pathways involved in sulforaphane (SF) mediated inhibition of the inflammatory response to lipopolysaccharide (LPS). Additionally, we investigated the effects of SF and LPS on the activity of Nrf2. MATERIAL: Primary rat microglia and the murine microglia cell line BV2 were used. TREATMENT: Cells were treated with LPS with or without SF. METHODS: Cell viability was measured via WST-assay. Real-time RT-PCR was performed to analyze cytokine mRNA levels. The nitric oxide (NO) release was measured in LPS-stimulated microglia. The induction of various signal transduction pathways and Nrf2 was determined by Western blotting. NF-kappaB and AP-1 activation was measured by dual luciferase assay. RESULTS: We showed that SF attenuates the LPS-induced increase of IL-1beta, IL-6, and TNF-alpha expression in microglia. In addition, SF significantly decreases the NO in a concentration-dependent manner. SF inhibits LPS-stimulated ERK1/2 and JNK phosphorylation and thereby inhibits the LPS-induced activation of NF-kappaB- and activator protein-1 (AP-1). Moreover, SF and LPS together are able to induce Nrf2 activation. CONCLUSIONS: We showed that SF, and also LPS by itself, are able to activate the cell's defence against oxidative and electrophilic stress. We conclude that SF could be a candidate agent for anti-inflammatory treatment of the central nervous system.


Subject(s)
Anti-Inflammatory Agents , Inflammation/prevention & control , Lipopolysaccharides/antagonists & inhibitors , Microglia/pathology , Thiocyanates/pharmacology , Animals , Blotting, Western , Cells, Cultured , Cytokines/biosynthesis , Extracellular Signal-Regulated MAP Kinases/metabolism , Inflammation/chemically induced , Isothiocyanates , JNK Mitogen-Activated Protein Kinases/metabolism , Luciferases/metabolism , Microglia/drug effects , Microglia/metabolism , NF-E2-Related Factor 2/biosynthesis , NF-E2-Related Factor 2/genetics , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Nitrites/metabolism , Phosphorylation , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Sulfoxides , Thiocyanates/adverse effects , Transcription Factor AP-1/antagonists & inhibitors
13.
Inflamm Res ; 58(10): 693-704, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19360377

ABSTRACT

OBJECTIVE: To seek a mechanism linking tobacco smoking with the increased incidence and severity of rheumatoid arthritis, deduced from many retrospective surveys, by studying arthritis/fibrosis development in rats. METHODS: Rats (>300) received low levels of sodium/potassium thiocyanate (10 or 25 mmol/l) in their drinking water to raise their blood thiocyanate levels, mimicking the elevated levels of blood, salivary and urinary thiocyanate found in smokers. RESULTS: Thiocyanate supplements increased the severity of experimental arthritis induced by tailbase injection of (1) Freund's complete adjuvants (mycobacteria plus various adjuvant-active oils), (2) collagen type-II with Freund's incomplete adjuvant (no mycobacteria), (3) the synthetic lipid amine, avridine in an oil and (4) the natural hydrocarbons squalene (C(30)H(50)) and pristane (C(19)H(40)). This pro-arthritic effect was independent of sex, rat strain or changing diet and housing facilities. Thiocyanate supplements also amplified the acute/persisting inflammatory responses to paw injections of pristane, zymosan and microcrystalline hydroxyapatite. Iodide salts also mimicked some of these effects of thiocyanate. CONCLUSION: Thiocyanate, a detoxication product of HCN present in tobacco smoke, increased (or even induced) inflammatory responses to several agents causing arthritis or fibrotic inflammation in rats. It, therefore, can act as a co-arthritigen, or 'virulence factor' and could be a therapeutic target to reduce arthritis expression and morbidity.


Subject(s)
Arthritis, Experimental/metabolism , Hydrogen Cyanide/metabolism , Inflammation/metabolism , Smoking/adverse effects , Thiocyanates/metabolism , Administration, Oral , Animals , Arthritis, Experimental/chemically induced , Arthritis, Experimental/microbiology , Collagen/adverse effects , Diamines/adverse effects , Disease Models, Animal , Female , Hydrocarbons/adverse effects , Male , Mycobacterium , Rats , Rats, Wistar , Severity of Illness Index , Thiocyanates/administration & dosage , Thiocyanates/adverse effects
14.
Thyroid ; 17(8): 741-6, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17725431

ABSTRACT

BACKGROUND: Exposure to environmental thiocyanate through smoking has been suggested to lead to hypothyroxinemia, which potentially impairs brain development in the fetuses of affected women, though studies are conflicting. It was hypothesized that iodine status might modulate the effects of thiocyanate exposure on the prevalence of hypothyroxinemia in women of childbearing age. DESIGN: The study population comprised 6967 women (age range: 15- 44 years) from the National Health and Nutrition Examination Survey (NHANES) III database. Smoking status was stratified into nonsmokers and those who smoked 1-10, 11-20, 21-30, and 31+ cigarettes a day. Iodine status was stratified based on urinary iodine excretion as <50, 50-99, 100-199, 200-299, and 300+ microug/L. Hypothyroxinemia was defined as the lower fifth percentile of total thyroxine levels among nonsmokers, adjusted for age and race/ethnicity. Univariate, multivariate, and regression analyses were conducted to evaluate the impact of smoking and urinary iodine excretion on the prevalence of hypothyroxinemia. RESULTS: Increasing levels of cigarette smoking are associated with increasing prevalence of hypothyroxinemia [chi(2)(4) = 14.15, p = 0.007]. When analyzed by urinary iodine level, the hypothyroxinemic effect of smoking was limited to the highest two urinary iodine strata [chi(2)(4) = 41.48, p < 0.001; and chi(2)(4) = 40.62, p < 0.001]. A significant interaction effect between smoking and urinary iodine was noted, underscoring the relationship between high levels of urinary iodine excretion and smoking with respect to hypothyroxinemia. CONCLUSIONS: Heavy smoking was associated with a higher prevalence of hypothyroxinemia. The impact of thiocyanate exposure from smoking on the prevalence of hypothyroxinemia is limited to those women of childbearing age with the highest urinary iodine excretion. Iodine supplementation should be cautiously considered in women of childbearing age who are smokers.


Subject(s)
Hypothyroidism/epidemiology , Iodine/adverse effects , Pregnancy Complications/epidemiology , Smoking/adverse effects , Smoking/epidemiology , Adolescent , Adult , Black People/statistics & numerical data , Databases, Factual , Female , Humans , Iodine/administration & dosage , Iodine/urine , Mexican Americans/statistics & numerical data , Nutrition Surveys , Pregnancy , Prevalence , Risk Factors , Thiocyanates/adverse effects , United States , White People/statistics & numerical data
16.
Braz. j. vet. res. anim. sci ; 43(supl): 93-101, 2006. tab, graf
Article in Portuguese | LILACS | ID: lil-473519

ABSTRACT

O objetivo do presente estudo foi verificar os efeitos sobre a cinética do cianeto, em suínos, em diferentes fases da vida, usando o tiocianato como biomarcador. Vinte e dois suínos, foram divididos em quatro grupos (60 dias da idade, 95 dias da idade, 80 dias do gestação e 21 dias de lactação), e receberam por via oral, a dose única de 3.0 mg /kg de peso vivo de cianeto do potássio (KCN). As concentrações do tiocianato no sangue foram medidas dentro de 24h. O tempo máximo (Tmax) e constante de eliminação (Kel) foram mais elevados em porcas lactantes (15 hs e 0.045, respectivamente); por ouro lado, a maior concentração do tiocianato (Cmax) foi observada nas fêmeas grávidas (161.8). A meia vida de eliminação (t1/2) e o volume da distribuição (Vd) foram mais elevados nas fêmeas adultas (41, 57 e 1.23, respectivamente). Contudo a área sob a curva (AUC) do tiocianato foi mais elevado nos animais novos (354183,28), e o clearance o mais baixo (0.007) nestes animais. Concluindo, os resultados do presente estudo, evidenciam que o metabolismo do cianeto, varia extremamente, considerando o estado fisiológico dos suínos fêmeas, e que são os animais novos, provavelmente, os mais sensíveis aos efeitos tóxicos, da exposição crônica as baixas doses do cianeto.


The aim of the present study was to determine the effects of the swine, in different periods of life on the toxicokinetics of cyanide using thiocyante as biomaker. Twenty and two swines, was divided into four groups (60 days of age, 95 days of age, sows with 80 days of gestation and lactating swine), were dosed orally with 3,0 mg/kg/ body weigth of potassium cyanide (KCN). Thiocyanate concentrations in blood were measured within 24h. The time of peak concentration (Tmax) and constant of elimination (Kel) were higher in lactating sows (15 hs and 0,045, respectively); on the other hand, the maximum plasma concentration (Cmax) of thiocyanate was observed in pregnant females (161,8). The elimination half life (t1/2) and volume of distribution (Vd) were higher in adult sows (41, 57 and 1,23, respectively). Whereas the clearance and the area under the curve (AUC) of thiocyanate was higher in young animals (354183,28) the clearance was lower (0,007) in these animals. In coclusion , the results of the present study evidence that the metabolism of cyanide varies greatly considering the physiologic state of female swine being the young animals probably more sensitive to the toxic effects of chronic exposure to low doses of cyanide.


Subject(s)
Animals , Female , Cyanides/adverse effects , Cyanides/metabolism , Cyanides/toxicity , Swine , Thiocyanates/analysis , Thiocyanates/adverse effects
17.
Biofactors ; 19(3-4): 107-11, 2003.
Article in English | MEDLINE | ID: mdl-14757960

ABSTRACT

Thiocyanate [SCN-] is a complex anion which is a potent inhibitor of iodide transport. It is the detoxification product of cyanide and can easily be measured in body fluids. Consumption of naturally occurring goitrogens, certain environmental toxins and cigarette smoke can significantly increase SCN- concentrations to levels potentially capable of affecting the thyroid gland. Goiter endemics were reported to develop when the critical urinary iodine/ SCN- ratio decreases below 3 microg iodine per mg SCN-. Iodine supplementation completely reverses the goitrogenic influence of SCN-. SCN- is also generated from cigarette smoking as a detoxifying product of cyanide. During the past two decades many reports dealt with the possible effects of cigarette smoking on thyroid hormone synthesis, thyroid gland size and thyroid autoimmunity including infiltrative ophtalmopathy of Graves' disease. In this mini-review, issues regarding thiocyanate overload and thyroid disease will be summarized.


Subject(s)
Smoking/adverse effects , Thiocyanates/adverse effects , Thyroid Diseases/chemically induced , Humans , Iodine/therapeutic use , Manihot/adverse effects , Thyroid Diseases/drug therapy , Thyroid Diseases/epidemiology
18.
Thyroid ; 12(10): 897-902, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12487772

ABSTRACT

Transport of iodine in the mammary gland into breast milk plays a central role in various fields of prevention of thyroid diseases. First, a sufficient content of iodine in the mother's milk is necessary for normal brain development in the breastfed child. This is attained by expression during lactation in the mammary gland of the sodium iodide symporter (NIS), also responsible for iodine transport in the thyroid. Milk iodine content varies with the iodine intake of the mother, and urinary iodine excretion in groups of mothers seems to be a valuable indicator of the iodine status of their breastfed children. Second, iodine in dairy products provides a considerable part of iodine intake in many populations. Thiocyanate from rapeseed feeding of cows decreases milk iodine content, probably by competitive inhibition of NIS in the mammary gland. Alterations in feeding of dairy cows may alter the iodine content of consumer milk, and this may influence the risk of thyroid diseases in the population. Thiocyanate inhibition of iodine transport into milk may also be operative in humans with a high thiocyanate intake. This could further impair iodine status in breastfed children in low-iodine intake areas of the world. It can be speculated that a low-iodine content of mother's milk because of inhibition of NIS in the mammary gland may be one factor of importance for development of myxedematous cretinism.


Subject(s)
Animal Feed , Congenital Hypothyroidism/etiology , Iodine/pharmacokinetics , Milk , Thiocyanates/adverse effects , Animals , Animals, Domestic , Brassica rapa , Breast Feeding , Cattle , Humans , Swine
19.
J Epidemiol Biostat ; 4(4): 285-95, 1999.
Article in English | MEDLINE | ID: mdl-10764242

ABSTRACT

BACKGROUND: Smoking is a well-known risk factor for coronary heart disease (CHD). The components of tobacco that cause CHD have not yet been established; nor have the relative dangers of cigarettes of different strengths. METHODS: This is a cohort study of 2,849 men and 2,900 women with no symptoms of CHD at baseline in the Scottish Heart Health Study. RESULTS: In a 7.7 year follow-up, to 1993, there were 123 male and 49 female CHD events. After adjusting for age, cholesterol and blood pressure, men who smoke > or = 20 cigarettes per day have a relative hazard [95% confidence interval (CI)] of 1.93 (1.15-3.24) compared with non-smokers; for women the corresponding relative hazard is 3.81 (2.00-7.27). Biochemical measures (cotinine, thiocyanate and expired-air CO) are closely correlated with self-reported smoking (0.67 < or = r < or = 0.72), and have similar relationships with CHD. Amongst cigarette smokers, relative hazards (third to first tertile), for tar yield are 1.05 (0.54-2.07) for men and 4.00 (1.13-14.18) for women. Nicotine and CO yields give similar results. Hazard ratios associated with heavy smoking and strong cigarettes are thus much higher for women. CONCLUSION: Although smoking was found to have a detrimental effect, this study was unable to suggest a single major cause of CHD. The excess effects found in women compared with men could be due to differences in former smoking habits. Furthermore, risk differences for smoking are slightly greater for men, explained by the relatively low incidence of CHD amongst women.


Subject(s)
Coronary Disease/epidemiology , Smoking/epidemiology , Adult , Biomarkers/analysis , Carbon Monoxide/adverse effects , Cohort Studies , Coronary Disease/etiology , Cotinine/adverse effects , Female , Humans , Incidence , Male , Middle Aged , Risk Factors , Scotland/epidemiology , Smoking/adverse effects , Surveys and Questionnaires , Thiocyanates/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...